BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16402454)

  • 1. [ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
    MMW Fortschr Med; 2005 Dec; 147(49-50):66-7. PubMed ID: 16402454
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
    Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
    Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
    van den Meiracker AH; van Montfrans GA
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 8. A new dimension in hypertension management with the amlodipine/perindopril combination.
    Poulter NR
    J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)].
    Widimský J
    Vnitr Lek; 2005 Dec; 51(12):1394-6, 1398-9. PubMed ID: 16430107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 12. Major trial shows cardiovascular benefits using new drug combination with perindopril.
    Cardiovasc J S Afr; 2005; 16(1):62. PubMed ID: 15778780
    [No Abstract]   [Full Text] [Related]  

  • 13. Older age should not be a barrier to the treatment of hypertension.
    Aronow WS
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschr Med; 2005 Sep; 147(39):12. PubMed ID: 16245771
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
    Prescrire Int; 2006 Jun; 15(83):112. PubMed ID: 16764103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will ASCOT change the form of anti-hypertensive therapy?
    Bilous R
    Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
    [No Abstract]   [Full Text] [Related]  

  • 17. Which patients benefit the most from the perindopril/amlodipine combination.
    Mourad JJ
    J Hypertens; 2011 Dec; 29 Suppl 1():S23-8. PubMed ID: 22157564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Strauss MH; Weinstein J; Newton GE
    N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888
    [No Abstract]   [Full Text] [Related]  

  • 20. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
    Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.